Article ; Online: A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.
2023 Volume 176, Page(s) 107647
Abstract: People with opioid use disorder (OUD) are overrepresented in US correctional facilities and experience disproportionately high risk for illicit opioid use and overdose after release. A growing number of correctional facilities offer medication for OUD ( ... ...
| Abstract | People with opioid use disorder (OUD) are overrepresented in US correctional facilities and experience disproportionately high risk for illicit opioid use and overdose after release. A growing number of correctional facilities offer medication for OUD (MOUD), which is effective in reducing these risks. However, a recent evaluation found that <50% of those prescribed MOUD during incarceration continued MOUD within 30 days after release, demonstrating a need to improve post-release continuity of care. We describe available evidence on contingency management (CM), an intervention wherein patients receive incentives contingent on behavior change, to achieve this goal. A prior systematic review reported strong evidence in support of CM for increasing treatment adherence in MOUD programs, but the trials reviewed did not include incarcerated participants. Research on CM to increase treatment adherence among participants in the criminal justice system is limited with mixed findings. However, in comparison to the trials that supported CM's efficacy in the community, CM trials in the criminal justice system provided smaller rewards with greater delays in the delivery of rewards to patients, which likely contributed to null findings. Indeed, a prior meta-analysis demonstrates a dose-response relationship between the magnitude and immediacy of reward and CM effectiveness. Thus, CM involving larger and more immediately delivered rewards are likely necessary to improve MOUD adherence during the critical period following release from incarceration. Future research on the effectiveness and implementation of CM to improve MOUD retention after release from incarceration is warranted. |
|---|---|
| MeSH term(s) | Humans ; Behavior Therapy ; Opioid-Related Disorders/drug therapy ; Drug Overdose ; Treatment Adherence and Compliance ; Prisoners ; Analgesics, Opioid ; Opiate Substitution Treatment ; Buprenorphine |
| Chemical Substances | Analgesics, Opioid ; Buprenorphine (40D3SCR4GZ) |
| Language | English |
| Publishing date | 2023-07-25 |
| Publishing country | United States |
| Document type | Meta-Analysis ; Journal Article |
| ZDB-ID | 184600-0 |
| ISSN | 1096-0260 ; 0091-7435 |
| ISSN (online) | 1096-0260 |
| ISSN | 0091-7435 |
| DOI | 10.1016/j.ypmed.2023.107647 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 878: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.